Clinical Trial: A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07633691) titled 'A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects' on June 01.

Brief Summary: This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Healthy Adult

Intervention: DRUG: DA-5223-R

once a day

DRUG: DA-5223-F

once a day

DRUG: DA-5223-M

once a day

Recruitment Status: RECRUITING

Sponsor: Dong-A ST Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily D...